Chris Gibson: Humbled to Receive the ‘Jensen Edition’ DGX Spark at JPM 2026
Chris Gibson/LinkedIn

Chris Gibson: Humbled to Receive the ‘Jensen Edition’ DGX Spark at JPM 2026

Chris Gibson, Co-Founder and Chair at Recursion, shared a post on LinkedIn:

“Huge thanks to NVIDIA Healthcare for bringing Najat Khan myself and a few other leaders together for a fantastic pre-reception at JPM. It is always energizing to get some Jensen Huang time and to hear his stories and perspectives from the last 33 years of building.

Also humbled to receive a ‘Jensen edition’ DGX Spark in recognition of the pioneering work of the incredible Recursion team – that GPU is gonna go br!

Cool to see Dave Ricks from Eli Lilly and Company on the main stage later talking about their huge collaboration with NVIDIA. While Recursion has technically lost the ‘fastest dedicated supercomputer of any biopharma’ title to Lilly (for now at least), their huge investments at the intersection of tech and bio are a blaring sign that the world is finally understanding the inevitability of TechBio.

That is good not just for Recursion, but for patients and the space.

Huge kudos to Kimberly Powell, Rory Kelleher and Anthony Costa and their teams, not just for a great night at JPM, but for the way they are helping to mold biopharma into TechBio!

It’s happening guys, finally!”

More posts featuring NVIDIA Healthcare.